Zacks Investment Research on MSN

PFE vs BMY: Which large oncology drugmaker is a better pick now?

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or ...
Forbes

Should You Pick PFE Stock At $25?

Pfizer stock (NYSE: PFE) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $17.8 billion and adjusted earnings of $0.63 per ...
Forbes

What’s Behind The Slump In Pfizer Stock?

Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...
CNN

Pfizer Inc.

PFE is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of PFE shares has decreased $0.44 since the market last closed. This is a 1.61% ...
Insider Monkey

Jim Cramer Warns on Pfizer (PFE): “That 7.7% Yield Is Not a Sign of Strength – It’s a Sign of Weakness”

We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer ...